Breaking News Instant updates and real-time market news.

GOOG

Alphabet

$1,249.25

17.77 (1.44%)

, GOOGL

Alphabet Class A

$1,264.72

18.78 (1.51%)

16:19
08/29/18
08/29
16:19
08/29/18
16:19

Fly Intel: Wall Street's top stories for Wednesday

Stocks opened little changed despite the release of an upwardly revised growth estimate for second quarter GDP. The market moved in a narrow range but drifted higher throughout the morning, pushing the Nasdaq and S&P to new highs. In addition to the GDP news, the market was also helped by reports of progress being made in U.S. trade talks with Canada. ECONOMIC EVENTS: In the U.S., Q2 GDP was revised up to a 4.2% growth rate from 4.1% in the advance report, which was better than the projected tick down to a 4.0% rate. An index of pending home sales dipped 0.7% to 106.2 in July, which was a little weaker than forecast. In White House news, the New York Times reported that trade talks between the U.S. and Canada had resumed, with both sides aiming to reach an agreement by the end of the week. Canada's foreign minister Chrystia Freeland said that she is "optimistic" that talks will progress in a positive direction, according to the Times. Later, CBC tweeted that U.S. President Donald Trump told reporters that he thinks the talks with Canada are on track for a deal by Friday. COMPANY NEWS: Shares of Google parent Alphabet (GOOGL) and Amazon (AMZN) advanced after Morgan Stanley analyst Brian Nowak raised his price targets for the stocks to $1,515 and $2,500, respectively. In addition to the high price targets, both companies have been in the spotlight after Senator Bernie Sanders accused the e-commerce giant of not paying its lower-level employees a fair wage and as President Trump slammed the search titan's service as "rigged"... Shares of Roku (ROKU) were under pressure, falling about 5% after The Information reported that an Amazon subsidiary is working on a free, ad-supported streaming service that sounds similar to what Roku is doing with The Roku Channel... Meanwhile, Reuters reported that President Trump has said that Google, Twitter (TWTR), and Facebook (FB) are "trying to silence people." The comment comes a day after Trump tweeted that Google's search results for "Trump News" were "rigged," doubling down later that Google, Facebook, and Twitter "have to be careful." MAJOR MOVERS: Among the noteworthy gainers was Glaukos (GKOS), which surged 40% after Novartis' (NVS) Alcon unit withdrew the CyPass micro-stent from the market due to safety concerns. Also higher was cannabis company Tilray (TLRY), which gained over 20% after reporting quarterly results. Among the notable losers were Movado (MOV) and Dick's Sporting Goods (DKS), which fell a respective 15% and 2% after reporting quarterly results. INDEXES: The Dow rose 60.55, or 0.23%, to 26,124.57, the Nasdaq gained 79.65, or 0.99%, to 8,109.69, and the S&P 500 advanced 16.52, or 0.57%, to 2,914.04.

GOOG

Alphabet

$1,249.25

17.77 (1.44%)

GOOGL

Alphabet Class A

$1,264.72

18.78 (1.51%)

AMZN

Amazon.com

$1,998.23

65.315 (3.38%)

ROKU

Roku

$59.90

-3.09 (-4.91%)

TWTR

Twitter

$35.35

-0.14 (-0.39%)

FB

Facebook

$175.96

-0.31 (-0.18%)

GKOS

Glaukos

$62.87

18.08 (40.37%)

NVS

Novartis

$83.67

-0.11 (-0.13%)

TLRY

Tilray

$62.06

10.795 (21.06%)

MOV

Movado

$41.75

-7.6 (-15.40%)

DKS

Dick's Sporting

$35.59

-0.8 (-2.20%)

  • 29

    Aug

  • 29

    Aug

  • 29

    Aug

  • 05

    Sep

  • 05

    Sep

  • 05

    Sep

  • 06

    Sep

  • 06

    Sep

  • 12

    Sep

  • 12

    Sep

  • 13

    Sep

  • 18

    Sep

  • 20

    Sep

  • 28

    Oct

GOOG Alphabet
$1,249.25

17.77 (1.44%)

08/29/18
MSCO
08/29/18
NO CHANGE
Target $1515
MSCO
Overweight
Alphabet price target raised to $1,515 from $1,325 at Morgan Stanley
Morgan Stanley analyst Brian Nowak raised his price target on shares of Alphabet to $1,515 from $1,325 citing the continued strong fundamentals in its core Google business as well as the growing visibility into its Waymo business. Nowak believes the current valuation of Alphabet ascribes little value for Waymo, but he also thinks the launch of Waymo's ride-hailing service by year-end can be a catalyst to realize that value. He currently values Waymo at $45B, or about $60 per Alphabet share, but notes this is only 25% of the $175B potential value he ascribes to the business. Nowak, who raised his 2018 and 2019 adjusted EBITDA estimates by 2%, keeps an Overweight rating on Alphabet shares.
08/07/18
MSCO
08/07/18
NO CHANGE
Target $1325
MSCO
Overweight
Enterprise value of Alphabet's Waymo raised to $175B at Morgan Stanley
Morgan Stanley analyst Brian Nowak increased his enterprise value estimate for Alphabet's Waymo unit from $75B for ride sharing only to $175B given his analyses for two other emerging business models, namely logistics and licensing. He believes Waymo remains on track to launch an autonomous ride hailing service in Phoenix this year and believes this business could be worth about $80B over the long-term. Partnerships with Walmart (WMT), DDR (DDR) and Peterbilt speak to Waymo's logistics focus, said Nowak, who sees the company potentially having a $90B logistics business. Additionally, he sees a roughly $7B licensing opportunity, pointing to the company's FCA (FCAU) relationship as a model of how companies could pay a license fee to Waymo for its autonomous technology. Given his view of Waymo being a key part of Alphabet's long-term value, Nowak raised his sum of the parts valuation to $1,550 from $1,400. He has an Overweight rating and $1,325 price target on Alphabet shares.
08/07/18
08/07/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. BOFA CUTS ZILLOW TO NEUTRAL: BofA Merrill Lynch analyst Nat Schindler downgraded Zillow (Z, ZG) to Neutral from Buy and cut its price target to $60 from $70 following the Q2 report and reduction in guidance. Schindler said the quarter indicated Zillow is taking longer than expected to ramp up the Homes business, Rentals revenue missed and the outlook was cut, and other revenue also missed, indicating the new construction opportunity is also taking longer to materialize. Zillow Class A shares are down about 17% in late morning trading. MORGAN STANLEY SAYS WAYMO COULD BE WORTH $175B: Morgan Stanley analyst Brian Nowak increased his enterprise value estimate for Alphabet's (GOOG, GOOGL) Waymo unit from $75B for ride sharing only to $175B given his analyses for two other emerging business models, logistics and licensing. He believes Waymo remains on track to launch an autonomous ride hailing service in Phoenix this year and believes this business could be worth about $80B over the long-term. Given his view of Waymo being a key part of Alphabet's long-term value, Nowak raised his sum of the parts valuation to $1,550 from $1,400. He has an Overweight rating and $1,325 price target on Alphabet shares. GOLDMAN RAISES NVIDIA TARGET AHEAD OF EARNINGS: Goldman Sachs analyst Toshiya Hari raised his price target for Nvidia (NVDA) to $324 from $310 ahead of quarterly results. Unlike the past 10 quarters where the company handily beat Street estimates and raised guidance, the analyst expects a "noisy" quarter with the focal points being the upcoming product transition in Gaming, the current product transition in Datacenter, weakness in cryptocurrency mining, and potential disruption from the virus attack at TSMC (TSM). That said, Hari noted that his long-term bull thesis on Nvidia remains intact and reiterated a Buy rating on the shares. ARGUS CUTS CBS TO HOLD: Argus analyst Joseph Bonner downgraded CBS (CBS) to Hold from Buy, noting significant downside risks for the company from both the sexual harassment allegations against CEO Moonves and the board's attempts to prevent the Viacom (VIA, VIAB) merger. Bonner noted that if the Moonves allegations are proven true, he would be immediately dismissed, which could end the board's bid to remain independent and thereby inflict damage on the shareholders.
08/09/18
STFL
08/09/18
DOWNGRADE
Target $2150
STFL
Hold
Booking Holdings downgraded to Hold on slowing growth at Stifel
As previously reported, Stifel analyst Scott Devitt downgraded Booking Holdings (BKNG) to Hold from Buy, citing the slowing growth at the company-formerly-known-as Priceline. Devitt lowered his core bookings growth expectations in 2018 and beyond following the company's Q2 earnings report and cut his price target on Booking shares to $2,150 from $2,332. He sees better large cap opportunities at company's with similar earnings multiples and better growth, such as Alibaba (BABA), Alphabet (GOOGL) and Facebook (FB), Devitt added.
GOOGL Alphabet Class A
$1,264.72

18.78 (1.51%)

08/22/18
MKMP
08/22/18
NO CHANGE
Target $1465
MKMP
Buy
Alphabet price target raised to $1,465 from $1,355 at MKM Partners
MKM Partners analyst Rob Sanderson raised his price target on Alphabet to $1,465 from $1,355 and kept his Buy rating, saying his revision removes the $5.1B E.U. fine while rolling out the valuation to 2021 in his model. Sanderson states that he remains impressed with Alphabet's "consistent growth at increasingly large revenue levels" and believes that the company's traffic acquisition costs could slow after a drag on earnings over a period of about 3 years, boosting its margins. The analyst adds that while Waymo has "negligible" near-term implications, its long-term potential is "tremendous".
08/29/18
08/29/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. MORGAN STANLEY RAISES ALPHABET, AMAZON TARGETS: Morgan Stanley analyst Brian Nowak raised his price target on shares of Alphabet (GOOGL) to $1,515 from $1,325 citing the continued strong fundamentals in its core Google business as well as the growing visibility into its Waymo business. Nowak, who raised his 2018 and 2019 adjusted EBITDA estimates by 2%, kept an Overweight rating on Alphabet shares. Additionally, Nowak expressed increasing confidence that Amazon's (AMZN) rapidly growing, high margin revenue streams will drive higher profitability and continue to push up consensus estimates. He has not made any changes to his estimates, but raised his price target on Amazon shares to $2,500 from $1,850 to reflect its improving business mix and his belief that the new target more accurately represents the company's long-term potential earnings power. He maintained an Overweight rating on Amazon shares. FERRARI UPGRADED TO BUY: HSBC analyst Giulio Pescatore upgraded Ferrari (RACE) to Buy and raised his price target for the shares to EUR 133 from EUR 114. The recent selloff on the CEO's comments regarding Sergio Marchionne's 2022 targets has provided an attractive entry point, Pescatore said. The analyst believes Ferrari's pipeline remains strong. ROYAL CARIBBEAN UPGRADED TO BUY: Deutsche Bank analyst Chris Woronka upgraded Royal Caribbean Cruises (RCL) to Buy and raised his price target for the shares to $146 from $135. The analyst finds the stock's valuation as "undemanding" at current share levels. Further, he sees the potential for more inflows into cruise stocks for the balance of 2018 as comps get tougher across sectors like lodging, retail, and Macau, but "relatively easier" for Royal Caribbean. JEFFERIES RAISES TARGET ON PAYPAL: Jefferies analyst John Hecht raised his price target for PayPal (PYPL) to $110 from $100 saying the company's growth story is more than just Venmo. While Venmo is an important growth driver, PayPal's core person-to-person business and mobile trends, which have been "impressive," should be followed more closely alongside the Venmo success, Hecht said. The analyst's updated analysis supports his belief that the eBay (EBAY) migration should be "very manageable" for PayPal. Further, his analysis of app downloads shows PayPal platforms "remain competitive." Hecht reiterated a Buy rating on the shares.
AMZN Amazon.com
$1,998.23

65.315 (3.38%)

08/29/18
JEFF
08/29/18
NO CHANGE
Target $40
JEFF
Buy
Tailored Brands shares now 'extremely cheap,' says Jefferies
Jefferies analyst Randal Konik says that while the CEO's retirement after recent share underperformance "doesn't look good optically and a preliminary 2Q comp would have helped," shares of Tailored Brands (TLRD) are "extremely cheap." Investors need to think through last night's release, Konik tells investors in a research note titled "Getting A New Tailor While Guidance Shows Biz Stable." Management changes can be good while Tailored is insulated from Amazon.com (AMZN) disintermediation and the job market and fashion trends provide upcoming catalysts, the analyst contends. He keeps a Buy rating on Tailored Brands with a $40 price target.
08/29/18
MSCO
08/29/18
NO CHANGE
Target $2500
MSCO
Overweight
Amazon price target raised to $2,500 from $1,850 at Morgan Stanley
Morgan Stanley analyst Brian Nowak expressed increasing confidence that Amazon's rapidly growing, high margin revenue streams - namely advertising, AWS, and subscriptions - will drive higher profitability and continue to push up consensus estimates. He has not made any changes to his estimates, but raised his price target on Amazon shares to $2,500 from $1,850 to reflect its improving business mix and his belief that the new target more accurately represents the company's long-term potential earnings power. In his new sum-of-the-parts model, Nowak values core retail at about $625B, values the AWS cloud business at roughly $375B, values Prime subscriber revenue at $100B and values the advertising business at $125B. He maintains an Overweight rating on Amazon shares, which closed yesterday at about $1,933 per share.
08/29/18
KEYB
08/29/18
NO CHANGE
KEYB
KeyBanc sees plenty of room for both Amazon, Roku given TV advertising TAM size
KeyBanc analyst Evan Wingren notes The Information has reported that Amazon's (AMZN) IMBD subsidiary is working on a free, ad-supported streaming service, which sounds similar to what Roku (ROKU) is doing with The Roku Channel. The analyst says he has long expected this to be part of Amazon's advertising strategy and that it would be announced at some point. Given the size of the TV advertising TAM that has not yet transitioned to streaming, Wingren sees "plenty of room for both companies to operate this strategy" for the foreseeable future and be successful. Overall, the analyst believes Amazon has the potential to create a very compelling value proposition to advertisers with good execution.
ROKU Roku
$59.90

-3.09 (-4.91%)

08/09/18
WBLR
08/09/18
NO CHANGE
WBLR
Outperform
Roku shares have additional 20% upside, says William Blair
William Blair analyst Ralph Schackart says that at the post-earnings share price of $51, Roku shares have additional upside around 20%. As the traditional TV ad market transitions in favor of over-the-top and streamed video, Roku is well positioned to take advantage, Schackart tells investors in a post-earnings research note. He believes the Roku Channel is making "significant progress" and keeps an Outperform rating on the shares.
08/10/18
DADA
08/10/18
NO CHANGE
Target $44
DADA
Neutral
Roku price target raised to $44 from $32 at DA Davidson
DA Davidson analyst Tom Forte raised his price target on Roku to $44 after its Q2 results, with sales, EPS, and EBITDA all beating expectations. The analyst cites a 57% increase in usage - above his forecast of 50% - along with a 46% increase in active accounts and an average revenue per user increase of 40%. Forte also keeps his Neutral rating on Roku, noting that the current share price likely reflects its long-term growth prospects.
08/28/18
LOOP
08/28/18
NO CHANGE
Target $52
LOOP
Hold
Roku price target raised to $52 from $43 at Loop Capital
Loop Capital analyst Alan Gould raised his price target on Roku to $52 to reflect his higher multiple estimate of 6.5-times his expected 2019 revenues, up from 5.5-times prior forecast. The analyst cites the company's continued market share capture of connected TVs, even though it faces a "substantial potential competition". Gould keeps a Hold rating on Roku, adding that there has recently been a "large amount of insider selling", even though he continues to expect the company to beat its quarterly estimates.
TWTR Twitter
$35.35

-0.14 (-0.39%)

07/31/18
07/31/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. JEFFERIES UPS RATING, TARGET FOR CHIPOTLE: Jefferies analyst Andy Barish upgraded Chipotle Mexican Grill (CMG) to Buy from Hold and raised his price target for the shares to $550 from $400. Barish believes Chipotle is one of the better positioned companies to benefit from the ongoing shift to digital/off-premise. The company's operations are now poised to again handle increased volume and throughput, the analyst contended. Further, he believes new management's plans are "credible" and should help drive results in 2019 and beyond. The analyst called the stock a top mid-cap pick. NOMURA UPGRADES TWITTER TO NEUTRAL: Nomura Instinet analyst Mark Kelley upgraded Twitter (TWTR) to Neutral from Reduce with an unchanged price target of $31. After selling off 27% since the Q2 earnings report on July 27, expectations have been appropriately reset, Kelley told investors. The analyst believes Twitter's investments to clean up the platform will prove a longer term positive and lead to a more engaged user base. BARCLAYS PREFERS DEERE TO CATERPILLAR: Barclays analyst Adam Seiden downgraded Caterpillar (CAT) to Equal Weight from Overweight and lowered his price target for the shares to $155 from $170. The company's largest end-markets are no longer at trough, and the analyst believes Caterpillar's second half of 2018 price initiatives, directed towards offsetting supply chain and materials cost increases, will limit its ability to expand margins. The analyst prefers shares of Deere (DE) and CNH Industrial (CNH), which he says are at similar valuations but are earlier in their market cycles. CITI SAYS SELL WISDOMTREE: Citi analyst William Katz placed a low probability on Franklin Resources (BEN) acquiring WisdomTree (WETF), and downgraded WisdomTree to Sell, lowering his price target for the shares to $7 from $10. The analyst downgraded the shares to Neutral on July 13. Katz believes WisdomTree's price-to-earnings multiple can further contract amid mixed flow dynamics and flat earnings growth prospects out to 2020. JPMORGAN SAYS GOPRO MAY SEE SHORT SQUEEZE: JPMorgan analyst Paul Coster believes "muted" expectations and elevated short-interest could position GoPro (GPRO) shares for a "short squeeze" rally after the company's Q2 results. The analyst expects the company to post an in-line quarter. GoPro must entice existing users to upgrade to a new flagship camera expected to be released in early Q4, and convert new users for a product category that "feels a bit long in the tooth now," Coster said. He lowered his price target for GoPro shares to $7 from $8 and kept a Neutral rating on GoPro.
07/31/18
NOMU
07/31/18
UPGRADE
Target $31
NOMU
Neutral
Nomura upgrades Twitter to Neutral on reset expectations
Nomura Instinet analyst Mark Kelley upgraded Twitter to Neutral from Reduce with an unchanged price target of $31. The stock closed yesterday down 8%, or $2.74, to $31.38. After selling off 27% since the Q2 earnings report on July 27, expectations have been appropriately reset, Kelley tells investors in a research note. The analyst believes Twitter's investments to clean up the platform will prove a longer term positive and lead to a more engaged user base. Further, he expects improving ad formats will drive advertiser retention and possibly growth over time.
07/31/18
07/31/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Twitter (TWTR) upgraded to Neutral from Reduce at Nomura Instinet analyst Mark Kelley saying after selling off 27% since the Q2 earnings report on July 27, expectations have been appropriately reset. 2. Chipotle (CMG) upgraded to Buy from Hold at Jefferies with analyst Andy Barish saying he believes Chipotle is one of the better positioned companies to benefit from the ongoing shift to digital/off-premise. 3. Affiliated Managers (AMG) upgraded to Outperform from Market Perform at Keefe Bruyette with analyst Robert Lee saying he believes the company is positioned for "at least" modest organic growth. 4. Booz Allen (BAH) upgraded to Outperform from Market Perform at Raymond James with analyst Brian Gesuale saying the Q1 report was "stellar," beating every key metric, while the share reaction was "lukewarm." 5. Northrop Grumman (NOC) upgraded to Buy on valuation at Buckingham with analyst Richard Safran saying the sell-off following the Q2 report provides an investment opportunity telling investors Defense spending and recent program wins may not be fully reflected in consensus expectations. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/31/18
NOMU
07/31/18
UPGRADE
Target $31
NOMU
Neutral
Twitter upgraded to Neutral from Reduce at Nomura Instinet
Nomura Instinet analyst Mark Kelley upgraded Twitter to Neutral following the recent pullback in the shares. The analyst has a $31 price target for the stock.
FB Facebook
$175.96

-0.31 (-0.18%)

08/21/18
LSCM
08/21/18
NO CHANGE
Target $4
LSCM
Buy
Sito Mobile price target lowered to $4 from $9 at Lake Street
Lake Street analyst Mark Argento blames Sito Mobile (SITO) management for misjudging the time it has taken to close deals, but he believes they have the right long-term vision and need to maximize the long-term opportunity while acknowledging "near-term realities," including the fact that Facebook (FB) data issues have touched off significant introspection by potential customers. He lowered his price target on the stock to $4 from $9 to reflect the continued push out of big data wins and uncertainty surrounding the legacy media placement business. While he now thinks Sito is "firmly in show-me territory," Argento keeps a Buy rating on the shares.
08/22/18
PIPR
08/22/18
NO CHANGE
Target $200
PIPR
Overweight
Piper survey shows most Facebook, Instagram users unfazed by recent issues
Piper Jaffray analyst Michael Olson says his firm's survey of 1,300 Facebook and Instagram users leaves him confident that "most are unfazed by the negative news flow." Facebook has had a rough year from a public relations perspective, with Cambridge Analytica, concern around "fake news" and privacy issues, Olson tells investors in a research note. However, the survey, which focused on usage of the services this year versus last year, found that the majority, or two-thirds, are using Facebook and Instagram the same or more versus last year, Olson writes. He believes the 21% pullback in Facebook shares since the July 25 close more than reflects issues surrounding Europe's new privacy laws as well as the rising cost of content security and screening. The analyst keeps an Overweight rating on Facebook shares with a $200 price target. The social media giant closed yesterday up 12c to $172.62.
08/22/18
08/22/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. SIDOTI UPGRADES SYSTEMAX TO BUY: Sidoti analyst Anthony Lebiedzinski upgraded Systemax (SYX) to Buy from Neutral. The analyst said the recent selloff in shares is overdone and maintained a $45 price target. Systemax shares are up 10.2% in morning trading. PIPER CUTS STARBUCKS TO NEUTRAL: Piper Jaffray analyst Nicole Miller Regan downgraded Starbucks (SBUX) last night to Neutral from Overweight and lowered her price target for the shares to $53 from $60. The motivation for the downgrade was another month of U.S. checks that suggested a lack of comp performance, Miller Regan said. The analyst believes shares of Starbucks will be "range bound at best" until U.S. trends improve. She sees issues around "inconsistent results, credibility of guidance, and management transitions." Miller Regan thinks the stock has "modest downside risk." MKM BOOSTS NETFLIX TARGET TO $395: MKM Partners analyst Rob Sanderson raised his price target for Netflix (NFLX) to $395 from $390 and kept a Buy rating on the shares after updating his estimates. The analyst said his "previous caution" on the shares is "now reversed" following the recent stock price correction. His subscriber ramp expectations are "somewhat lower" in the near-to-medium term but remain unchanged in the long-term. Netflix will approach full penetration of the U.S. over time, growing to 90M subscribers by 2025, Sanderson said. He continues to see over $40 per share in earnings power at 90M U.S. and 300M international subscribers, which he projected in the 2025 timeframe. Expectations for Netflix became "somewhat elevated, but have been appropriately moderated," Sanderson contended. He called the stock a "must-own for growth managers." BAIRD SAYS STAR WARS LICENSE ADDS VISIBILITY FOR ZYNGA: Baird analyst Colin Sebastian believes the Star Wars license announced adds some visibility to Zynga's (ZNGA) out-year growth targets. The new Disney (DIS) license is a positive development for Zynga for the longer-term given the popularity of the Star Wars franchise, Sebastian said. That said, he does not expect a material contribution from new titles until 2020. As such, Sebastian kept a Neutral rating on Zynga shares. Znga shares are up 7.6% in late morning trading. PIPER SAYS FACEBOOK USERS 'UNFAZED' BY ISSUES: Piper Jaffray analyst Michael Olson said his firm's survey of 1,300 Facebook (FB) and Instagram users leaves him confident that "most are unfazed by the negative news flow." The analyst kept an Overweight rating on Facebook shares with a $200 price target.
08/29/18
KEYB
08/29/18
NO CHANGE
Target $215
KEYB
Overweight
Facebook shift to stories should strengthen platform, says KeyBanc
KeyBanc analyst Andy Hargreaves views Facebook's shift toward stories as a positive for the longer-term health of the platform and for the advertising opportunity. While the transition is likely to sacrifice short-term growth, the analyst believes it can improve engagement and broaden Facebook's attraction to brand advertisers. He reiterates an Overweight rating and a $215 price target on the shares.
GKOS Glaukos
$62.87

18.08 (40.37%)

08/29/18
JPMS
08/29/18
UPGRADE
Target $75
JPMS
Overweight
JPMorgan upgrades Glaukos after 'main competitor' pulls product
As previously reported, JPMorgan analyst Robert Marcus upgraded Glaukos (GKOS) to Overweight from Neutral, calling Alcon's (NVS) voluntary withdrawal of its micro-stent from the market a "significant win" that opens up an opportunity for Glaukos to take back principally all of the sales being generated by CyPass. Stating that he's always been a firm believer in Glaukos' pipeline and technology, Marcus said competition had been the main factor keeping him on the sidelines. Now that its "main competitor" is out of the way, he sees Glaukos having a meaningful opportunity to recapture share and lead the market. Marcus raised his price target on the stock to $75 from $42.
08/29/18
JPMS
08/29/18
UPGRADE
JPMS
Overweight
Glaukos upgraded to Overweight from Neutral at JPMorgan
08/29/18
SPHN
08/29/18
NO CHANGE
Target $57
SPHN
Overweight
Glaukos price target raised to $57 at Stephens after Novartis withdraws CyPass
Stephens analyst Chris Cooley raised his price target on Glaukos (GKOS) shares to $57 from $50 after Novartis' (NVS) Alcon unit withdrew the CyPass micro-stent from the market due to safety concerns. He estimates $40M-$50M in annual sales are now "in play" and see Glaukos as the most likely beneficiary, Cooley tells investors. He maintains an Overweight rating on Glaukos shares, which are up $17.35, or 39%, to $62.15 in pre-market trading.
08/29/18
PIPR
08/29/18
NO CHANGE
Target $55
PIPR
Overweight
Piper sees CyPass withdrawal as 'major boon' for Glaukos, ups target to $55
Piper Jaffray analyst Matt O'Brien views Alcon's immediate withdrawal of its CyPass stent for the treatment of glaucoma on safety concerns from a recently completed clinical study as a "major boon" for Glaukos (GKOS). The analyst suspects it will be several quarters before CyPass comes back to the market, with with a much narrower indication. This is a "major positive" for Glaukos as most of the clinicians using CyPass had been or are still using iStent from Glaukos, O'Brien tells investors in a research note. He anticipates many clinicians will quickly shift their volumes back to iSten, yielding "significant incremental revenues." Based on this morning's news, the analyst raised his price target for Glaukos shares to $55 from $46. He encourages investors to start or build positions in the name.
NVS Novartis
$83.67

-0.11 (-0.13%)

08/29/18
WBLR
08/29/18
NO CHANGE
WBLR
Outperform
CyPass market removal a 'clear positive' for Glaukos, says William Blair
William Blair analyst Brian Weinstein believes Alcon's voluntary global market withdrawal of its CyPass Micro-Stent for surgical glaucoma is a "clear positive for near-term numbers" at Glaukos (GKOS). If Glaukos' iStent takes all of the CyPass market share while it is off the market, the company could add as much as $50M in the U.S. alone to its 2019 total revenue of around $186M, Weinstein tells investors in a research note, while admitting this is a bullish stance. The analyst thinks the news this morning from Alcon should be viewed as a positive for Glaukos, as a major part of the short thesis was on competition in the core iStent market, mainly from Alcon. He keeps an Outperform rating on Glaukos shares.
TLRY Tilray
$62.06

10.795 (21.06%)

08/14/18
ROTH
08/14/18
INITIATION
Target $35
ROTH
Buy
Tilray initiated with a Buy at Roth Capital
Roth Capital analyst Charles Finnie started Tilray with a Buy rating and $35 price target. Although not the largest player, the company's unsurpassed product quality and cultivation expertise compare favorably to the leading Canadian Licensed Producers, he contends. The analyst expects revenues to grow at 40% plus annual rate over the next three to five years, with earnings growing considerably faster with expected operating margin expansion.
08/29/18
08/29/18
DOWNGRADE
Target $54

Neutral
Tilray downgraded to Neutral on valuation at Roth Capital
As previously reported, Roth Capital analyst Charles Finnie downgraded Tilray (TLRY) to Neutral from Buy, citing valuation, noting that the stock has advanced nearly 2.5 times since going public last month. While Tilray reported strong results and "appears to be on track for a very impressive 2019," Finnie believes the stock's current levels reflect "a highly speculative M&A scenario" following Constellation's (STZ) $4B investment in market leader Canopy Growth (CGC), he tells investors. Though he cut his rating, Finnie raised his price target on Tilray shares to $54 from $35.
08/27/18
COWN
08/27/18
NO CHANGE
Target $34
COWN
Outperform
Tilray remains well positioned in cannabis market, says Cowen
Cowen analyst Vivien Azer believes Tilray remains well positioned to benefit from a legal recreational cannabis market in Canada. She noted it is an emerging industry and is subject to regulatory headwinds and she believes much work is needed for the industry to reach its full potential. Azer reiterated her Outperform rating on Tilray shares with a price target of $34. Tilray shares closed at $43.86 on Friday and in pre-market trading are up nearly 15% to $50.34.
08/29/18
ROTH
08/29/18
DOWNGRADE
ROTH
Neutral
Tilray downgraded to Neutral from Buy at Roth Capital
MOV Movado
$41.75

-7.6 (-15.40%)

08/22/18
SIDC
08/22/18
UPGRADE
SIDC
Buy
Movado upgraded to Buy from Neutral at Sidoti
06/12/18
SIDC
06/12/18
DOWNGRADE
SIDC
Neutral
Movado downgraded to Neutral from Buy at Sidoti
DKS Dick's Sporting
$35.59

-0.8 (-2.20%)

08/20/18
SUSQ
08/20/18
NO CHANGE
SUSQ
Positive
Nervousness not necessary ahead of footwear retailers' results, says Susquehanna
Susquehanna analyst Sam Poser noted investors are very nervous regarding earnings of footwear retailers, but he sees little to no reason for such nervousness. The analyst believes Dick's Sporting (DKS), Foot Locker (FL), and Hibbett Sports (HIBB) are well positioned heading into earnings. The analyst said product assortment is improving, inventory levels are as clean as they have been in years, and based on forward weeks of supply, all three are at historic lows. Poser believes the combination of better product and clean inventory will provide a revenue and margin tailwind in Q2 and beyond. Poser has a Positive rating on Dick's Sporting, Foot Locker, and Hibbett Sports shares.
08/29/18
BARD
08/29/18
NO CHANGE
Target $27
BARD
Outperform
Under Armour selloff on Dick's 'head fake' a buying opportunity, says Baird
Baird analyst Jonathan Komp noted that while Dick's Sporting Goods (DKS) reported its own "disappointing" earnings, the company called out continued sales challenges for Under Armour (UAA), which it attributed to expanded distribution. He believes current sporting goods disruption for Under Armour is already reflected in the company's 2018 earnings guidance and also believes other mid-tier channels have continued to show strong sales performance, pointing out that Kohl's (KSS) saw Under Armour accelerate in Q2. Komp, who views the selloff on Dick's comments a "compelling buying opportunity," keeps an Outperform rating and $27 price target on Under Armour Class A shares.
08/29/18
WELS
08/29/18
NO CHANGE
WELS
Outperform
Dick's Sporting earnings pullback as a buying opportunity, says Wells Fargo
Wells Fargo analyst Ike Boruchow recommends using today's post-earnings weakness in shares of Dick's Sporting Goods as a buying opportunity. Despite missing Q2 comp expectations, merchandise margin improved 140 basis points year-over-year and gross profit dollars came in about $10M above consensus, Boruchow tells investors in a research note. The analyst is encouraged by Dick's investments to drive productivity improvements in both stores and e-commerce. He sees lots of room for multiple expansion and upside to estimates and keeps an Outperform rating on the shares.
08/15/18
OTRG
08/15/18
UPGRADE
OTRG
Positive
Dick's Sporting upgraded to Positive following checks at OTR Global
OTR Global upgraded Dick's Sporting to Positive from Mixed following checks that indicate Q2 sales were aided by favorable weather, increased customer interest in branded products, and price-matching programs.

TODAY'S FREE FLY STORIES

CMCSA

Comcast

$37.91

0.1 (0.26%)

, CMCSK

Comcast

$0.00

(0.00%)

14:32
09/22/18
09/22
14:32
09/22/18
14:32
Periodicals
Comcast outbids Fox in battle for Sky, Reuters reports »

Comcast (CMCSA; CMCSK)…

CMCSA

Comcast

$37.91

0.1 (0.26%)

CMCSK

Comcast

$0.00

(0.00%)

FOX

21st Century Fox

$43.97

-0.23 (-0.52%)

FOXA

21st Century Fox

$44.33

-0.26 (-0.58%)

SKYAY

Sky

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BOKF

BOK Financial

$104.69

-0.08 (-0.08%)

, COBZ

CoBiz Financial

$23.44

0.01 (0.04%)

13:36
09/22/18
09/22
13:36
09/22/18
13:36
Conference/Events
CoBiz Financial to host special shareholder meeting »

Special Shareholder…

BOKF

BOK Financial

$104.69

-0.08 (-0.08%)

COBZ

CoBiz Financial

$23.44

0.01 (0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 27

    Sep

AMRH

AMERI Holdings

$1.44

-0.04 (-2.70%)

13:30
09/22/18
09/22
13:30
09/22/18
13:30
Conference/Events
AMERI Holdings to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

BRK.A

Berkshire Hathaway

$331,710.00

-1090 (-0.33%)

13:26
09/22/18
09/22
13:26
09/22/18
13:26
Periodicals
Berkshire Hathaway still looks underpriced, Barron's says »

Class A shares of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLGO

BioLargo

$0.00

(0.00%)

13:11
09/22/18
09/22
13:11
09/22/18
13:11
Conference/Events
BioLargo to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CZWI

Citizens Community Bancorp

$14.13

0.03 (0.21%)

12:56
09/22/18
09/22
12:56
09/22/18
12:56
Conference/Events
Citizens Community Bancorp to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SF

Stifel Financial

$54.86

-0.78 (-1.40%)

12:50
09/22/18
09/22
12:50
09/22/18
12:50
Conference/Events
Stifel Financial to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBCT

People's United

$17.94

-0.055 (-0.31%)

, FBNK

First Connecticut

$30.95

0.1 (0.32%)

12:47
09/22/18
09/22
12:47
09/22/18
12:47
Conference/Events
First Connecticut to host special shareholder meeting »

Special shareholder…

PBCT

People's United

$17.94

-0.055 (-0.31%)

FBNK

First Connecticut

$30.95

0.1 (0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 18

    Oct

ASPS

Altisource

$34.10

-0.09 (-0.26%)

12:44
09/22/18
09/22
12:44
09/22/18
12:44
Conference/Events
Altisource to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$217.65

-2.35 (-1.07%)

, CSCO

Cisco

$48.51

0.77 (1.61%)

12:36
09/22/18
09/22
12:36
09/22/18
12:36
Periodicals
Apple, Microsoft among stocks with solid dividends, Barron's says »

Technology stocks are not…

AAPL

Apple

$217.65

-2.35 (-1.07%)

CSCO

Cisco

$48.51

0.77 (1.61%)

IBM

IBM

$151.29

0.12 (0.08%)

MSFT

Microsoft

$114.70

1.13 (0.99%)

ORCL

Oracle

$51.08

0.65 (1.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 25

    Sep

  • 26

    Sep

  • 26

    Sep

  • 26

    Sep

  • 27

    Sep

  • 03

    Oct

  • 04

    Oct

  • 05

    Oct

  • 10

    Oct

  • 21

    Oct

  • 22

    Oct

  • 22

    Oct

  • 24

    Oct

  • 25

    Oct

  • 28

    Oct

  • 28

    Nov

  • 03

    Mar

CAT

Caterpillar

$156.39

0.38 (0.24%)

, AMAT

Applied Materials

$39.62

0.22 (0.56%)

12:28
09/22/18
09/22
12:28
09/22/18
12:28
Periodicals
Caterpillar, KeyCorp among stocks to buy as bond yields rise, Barron's says »

As the economy improves,…

CAT

Caterpillar

$156.39

0.38 (0.24%)

AMAT

Applied Materials

$39.62

0.22 (0.56%)

BWA

BorgWarner

$45.24

-0.53 (-1.16%)

KEY

KeyCorp

$20.78

0.02 (0.10%)

PH

Parker-Hannifin

$190.52

0.01 (0.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Sep

  • 18

    Oct

  • 25

    Oct

  • 30

    Oct

BSX

Boston Scientific

$37.76

-0.07 (-0.19%)

, ISRG

Intuitive Surgical

$556.70

-4.43 (-0.79%)

10:34
09/22/18
09/22
10:34
09/22/18
10:34
Periodicals
'Good time' to think about device markers, Barron's says »

Medical technology stocks…

BSX

Boston Scientific

$37.76

-0.07 (-0.19%)

ISRG

Intuitive Surgical

$556.70

-4.43 (-0.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Oct

TLRY

Tilray

$123.16

-53.365 (-30.23%)

10:20
09/22/18
09/22
10:20
09/22/18
10:20
Periodicals
Marijuana stocks 'the new Bitcoin,' Barron's says »

Led by Tilray, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$217.65

-2.35 (-1.07%)

, WMT

Walmart

$95.85

0.1 (0.10%)

09:05
09/22/18
09/22
09:05
09/22/18
09:05
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AAPL

Apple

$217.65

-2.35 (-1.07%)

WMT

Walmart

$95.85

0.1 (0.10%)

DE

Deere

$152.82

-1.24 (-0.80%)

AGCO

Agco

$60.24

-0.9 (-1.47%)

ADM

Archer Daniels

$50.33

(0.00%)

MOS

Mosaic

$32.33

0.02 (0.06%)

CF

CF Industries

$52.82

-0.48 (-0.90%)

SPWR

SunPower

$7.88

-0.18 (-2.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 28

    Oct

  • 06

    Nov

  • 13

    Nov

  • 15

    Nov

  • 03

    Mar

AERI

Aerie Pharmaceuticals

$58.50

0.1 (0.17%)

, AGN

Allergan

$191.34

-1.11 (-0.58%)

04:55
09/22/18
09/22
04:55
09/22/18
04:55
Conference/Events
European Society of Retina Specialists to hold a conference »

18th Congress of EURETINA…

AERI

Aerie Pharmaceuticals

$58.50

0.1 (0.17%)

AGN

Allergan

$191.34

-1.11 (-0.58%)

ALIM

Alimera Sciences

$1.07

(0.00%)

BABY

Natus Medical

$34.45

-0.2 (-0.58%)

BHC

Bausch Health

$24.92

-0.07 (-0.28%)

BAYRY

Bayer

$0.00

(0.00%)

ELXMF

Ellex Medical Lasers

$0.00

(0.00%)

GKOS

Glaukos

$58.78

-1.69 (-2.79%)

IRIX

IRIDEX

$6.52

0.08 (1.24%)

JNJ

Johnson & Johnson

$142.85

0.85 (0.60%)

NITE

Nightstar Therapeutics

$25.64

-1.71 (-6.25%)

NVS

Novartis

$85.46

-0.505 (-0.59%)

OCUL

Ocular Therapeutix

$6.45

0.03 (0.47%)

RHHBY

Roche

$0.00

(0.00%)

SHPG

Shire

$178.32

-1.68 (-0.93%)

STAA

STAAR Surgical

$47.00

-0.9 (-1.88%)

TMDI

Titan Medical

$2.24

0.02 (0.90%)

TTNP

Titan Pharmaceuticals

$0.22

-0.2833 (-56.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 24

    Sep

  • 25

    Sep

  • 27

    Sep

  • 01

    Oct

  • 03

    Oct

  • 09

    Oct

  • 16

    Oct

  • 22

    Oct

  • 28

    Oct

  • 29

    Oct

  • 15

    Nov

  • 27

    Nov

  • 21

    Dec

  • 28

    Dec

  • 15

    Feb

  • 25

    Feb

CDTI

CDTi

$0.34

0.01 (3.08%)

18:15
09/21/18
09/21
18:15
09/21/18
18:15
Hot Stocks
CDTi sees September 21 as effective date of reverse stock split »

CDTi Advanced Materials…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DUK

Duke Energy

$79.82

-0.81 (-1.00%)

18:08
09/21/18
09/21
18:08
09/21/18
18:08
Hot Stocks
Duke Energy restored nearly 1.8M outages in NC, SC during past week »

Duke Energy crews today…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 02

    Oct

  • 03

    Oct

  • 04

    Oct

  • 11

    Nov

JNJ

Johnson & Johnson

$142.85

0.85 (0.60%)

18:01
09/21/18
09/21
18:01
09/21/18
18:01
Hot Stocks
Johnson & Johnson's Janssen discloses phase 3 study results of Esketamine »

The Janssen…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 28

    Oct

UAL

United Continental

$89.94

0.8 (0.90%)

17:39
09/21/18
09/21
17:39
09/21/18
17:39
Periodicals
United pilots refuse contract changes on regional routes, Reuters says »

United Airlines pilots…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

XLE

Energy Select Sector SPDR

$75.11

0.5132 (0.69%)

, XLU

Utilities SPDR

$53.04

0.2049 (0.39%)

17:36
09/21/18
09/21
17:36
09/21/18
17:36
General news
Week ending ETF Scorecard: Materials outperform, Utlilites slump »

S&P500 SECTORS:…

XLE

Energy Select Sector SPDR

$75.11

0.5132 (0.69%)

XLU

Utilities SPDR

$53.04

0.2049 (0.39%)

IYR

DJ US Real Estate Index Fund

$81.88

-0.06 (-0.07%)

XLP

Consumer Staples Sector SPDR

$55.02

0.1285 (0.23%)

XLY

Consumer Discretionary Sector SPDR

$116.98

-0.4288 (-0.37%)

XLB

S&P Select Materials SPDR

$60.54

-0.1312 (-0.22%)

XLF

Financial Select Sector

$28.73

-0.1175 (-0.41%)

XLV

Health Care Select Sector SPDR

$94.26

0.1571 (0.17%)

XLK

Technology Select Sector SPDR

$74.68

-0.2056 (-0.27%)

XLI

Industrial Select Sector SPDR

$79.71

0.2338 (0.29%)

GLD

SPDR Gold Trust

$113.48

-0.77 (-0.67%)

SLV

iShares Silver Trust

$13.44

-0.01 (-0.07%)

USO

United States Oil Fund

$14.95

0.145 (0.98%)

UNG

United States Natural Gas Fund

$24.60

0.235 (0.96%)

HYG

iShares iBoxx $ High Yield Corporate Bond

$86.24

0.05 (0.06%)

LQD

iShares iBoxx $ Investment Grade Corporate Bond

$114.72

0.04 (0.03%)

TLT

iShares 20+ Year Treasury Bond Fund

$117.12

-0.02 (-0.02%)

IEF

iShares 7-10 Year Treasury Bond ETF

$101.00

0.03 (0.03%)

SHY

iShares 1-3 Year Treasury Bond

$83.05

0.02 (0.02%)

IWD

iShares Russell 1000 Value

$129.51

0.13 (0.10%)

IWF

iShares Russell 1000 Growth

$155.30

-0.55 (-0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OHGI

One Horizon Group

$0.18

-0.0088 (-4.63%)

17:34
09/21/18
09/21
17:34
09/21/18
17:34
Syndicate
Breaking Syndicate news story on One Horizon Group »

One Horizon Group files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYTX

Cytori Therapeutics

$0.41

-0.033 (-7.38%)

17:31
09/21/18
09/21
17:31
09/21/18
17:31
Syndicate
Breaking Syndicate news story on Cytori Therapeutics »

Cytori Therapeutics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NEM

Newmont Mining

$31.56

0.05 (0.16%)

17:22
09/21/18
09/21
17:22
09/21/18
17:22
Syndicate
Breaking Syndicate news story on Newmont Mining »

Newmont Mining files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 25

    Oct

CB

Chubb

$139.87

-0.05 (-0.04%)

17:22
09/21/18
09/21
17:22
09/21/18
17:22
Hot Stocks
Chubb CEO Greenberg sells $8.6M in common stock »

Chubb CEO Evan Greenberg…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VTVT

vTv Therapeutics

$0.80

0.0096 (1.21%)

17:21
09/21/18
09/21
17:21
09/21/18
17:21
Hot Stocks
vTv says FDA advised that azeliragon efficacy be shown in at least 2 trials »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.